MRVL heads into its May 27 earnings call with analyst conviction running well ahead of the stock — and options traders growing quietly more defensive.
The most striking dynamic this week is the gap between where the Street sees value and where the stock is trading. UBS analyst Timothy Arcuri raised his price target to $195 on May 4, a $75 lift from his prior $120, while maintaining a Buy rating. That single move followed a broader pattern of upward revisions across the analyst community: Oppenheimer, B. Riley Securities, and Barclays all lifted targets through April, with Barclays upgrading from Equal-Weight to Overweight on April 9. The bull case rests on data centre momentum — Marvell's interconnect business is guiding to better than 50% year-over-year growth in FY27 — and sequential recovery in its communications end markets. The bear case is more nuanced: valuation looks undemanding on a CY27 PEG basis, but gross margin pressure and any softening in hyperscaler capex could weigh. With MRVL at $164.50 and the consensus mean price target at $120.88, there is a notable disconnect — the target likely reflects a lagged consensus that has not fully absorbed the most recent upgrades, which skew materially higher.
Options positioning has shifted more defensive. The put/call ratio has climbed to 1.30, above its 20-day average of 1.22, and is running closer to the 52-week high of 1.39 than at any point since early April. That marks about one standard deviation of extra caution relative to the recent baseline. The drift has been gradual and consistent over the past two weeks, suggesting it reflects pre-earnings hedging rather than a single shock. Close peers moved in a similar direction on the day: fell 2.2%, dropped 3.7%, and lost 4.6%, suggesting broader semiconductor sector pressure rather than MRVL-specific selling.
Short interest is rebuilding modestly but tells a calm story overall. At 3.6% of the free float, it has risen about 3.6% over the past week — coming off a low set around late April — but remains well below the elevated levels seen in early April, when SI was running nearer 3.8-3.9%. The borrow market is extremely loose: cost to borrow is less than 0.26% annualised, and availability is far from stressed, with the 52-week lending utilisation peak at only 7.25%. There is no meaningful squeeze dynamic here.
Institutional ownership adds a layer of confidence to the bull case. FMR (Fidelity's parent) added more than 6 million shares in the last reported period to hold 13.8% of the company. BlackRock added 3.4 million shares and State Street added 1.7 million, both reporting as of April 30. These are incremental adds across major passive and active platforms, not rotations.
On the insider side, recent activity skewed toward selling. President and COO Christopher Koopmans sold $1.6 million worth of stock on May 1, and division president Sandeep Bharathi sold an $8.7 million block in mid-April. CEO Matt Murphy received a large equity award on April 15, but no corresponding open-market purchases are visible in the 90-day window. Net insider value over 90 days is roughly $67 million sold against awards, which reflects routine executive compensation activity more than a directional signal.
The last earnings print — March 5 — delivered a one-day gain of nearly 15% and a five-day gain of 12%. The May 27 report is the next event worth watching, and whether the data centre interconnect growth trajectory can clear the bar that UBS and Barclays' recently elevated targets have now implied.
See the live data behind this article on ORTEX.
Open MRVL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
